Skip to main content

CORRECTION article

Front. Allergy, 09 September 2022
Sec. Rhinology
This article is part of the Research Topic Insights in Rhinology: 2021/22 View all 9 articles

Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA

\r\nLouise De Prins,Louise De Prins1,2Ulrike Raap,Ulrike Raap3,4Tara Mueller,Tara Mueller3,4Peter Schmid-Grendelmeier,Peter Schmid-Grendelmeier1,5Christiane H. HaaseChristiane H. Haase6Vibeke Backer,Vibeke Backer1,6Wytske Fokkens,Wytske Fokkens1,7Linda B. BenoistLinda B. Benoist7Emmanuel Prokopakis,Emmanuel Prokopakis1,8Maria DoulaptsiMaria Doulaptsi8Claire Hopkins,Claire Hopkins1,9Nele ClaeysNele Claeys10Thijs TeelingThijs Teeling10Lindsay Cypers
Lindsay Cypers1*Leen Cools,Leen Cools1,2Leif H. BjermerLeif H. Bjermer1Zuzana DiamantZuzana Diamant1Ulrich WahnUlrich Wahn1Glenis ScaddingGlenis Scadding1Claus BachertClaus Bachert11Peter WaltherPeter Walther1Sunni R. PatelSunni R. Patel1Elizabeth Van StaeyenElizabeth Van Staeyen1Peter Hellings,,,\r\nPeter Hellings1,2,7,11
  • 1Department of Otorhinolaryngology, EUFOREA Scientific Expert Team Members, Brussels, Belgium
  • 2Department of Otorhinolaryngology, Head and Neck Surgery, Universitair Ziekenhuis Leuven, Leuven, Belgium
  • 3Division of Experimental Allergology and Immunodermatology, University of Oldenburg, Oldenburg, Germany
  • 4Department of Dermatology, Klinikum Oldenburg, University of Oldenburg, Oldenburg, Germany
  • 5Department of Dermatology, Allergy Unit, University Hospital of Zurich, Zurich, Switzerland
  • 6Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
  • 7Department of Otorhinolaryngology, Head / Neck Surgery, Academic Medical Center (AMC), Amsterdam, Netherlands
  • 8Department of Otorhinolaryngology-Head and Neck Surgery, University of Crete School of Medicine, Heraklion, Crete, Greece
  • 9Department of Otorhinolaryngology, Guy’s and St Thomas’ Hospital, London Bridge Hospital, London, United Kingdom
  • 10EUFOREA Patient Advisory Board Chairs
  • 11Upper Airways Research Laboratory, Department of Otorhinolaryngology, University of Ghent, Ghent, Belgium

A corrigendum on

White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA

By De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, Fokkens W, Benoist LB, Prokopakis E, Hopkins C, Claeys N, Teeling T, Cools LCL, Bjermer LH, Diamant Z, Wahn U, Scadding G, Bachert C, Patel SR, Van Staeyen E and Hellings P. (2022). Front. Allergy. 3:889221. doi: 10.3389/falgy.2022.889221

Error in author list

In the published article, there was an error in the author list, and authors Maria Doulaptsi and Peter Walther were erroneously excluded. The corrected author list appears below.

Louise De Prins1,2

Ulrike Raap3,4

Tara Mueller3,4

Peter Schmid-Grendelmeier1,5

Christiane H. Haase6

Vibeke Backer1,6

Wytske Fokkens1,7

Linda B. Benoist7

Emmanuel Prokopakis1,8

Maria Doulaptsi8

Claire Hopkins1,9

Nele Claeys10

Thijs Teeling10

Lindsay Cypers1*

Leen Cools1,2

Leif H. Bjermer1

Zuzana Diamant1

Ulrich Wahn1

Glenis Scadding1

Claus Bachert11

Peter Walther1

Sunni R. Patel1

Elizabeth Van Staeyen1

Peter Hellings1,2,7,11

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: atopic dermatitis (AD), asthma, chronic rhinosinusitis, nasal polyps, type 2 inflammation, quality of life, unmet needs

Citation: De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, Fokkens W, Benoist LB, Prokopakis E, Doulaptsi M, Hopkins C, Claeys N, Teeling T, Cypers L, Cools L, Bjermer LH, Diamant Z, Wahn U, Scadding G, Bachert C, Walther P, Patel SR, Van Staeyen E and Hellings P (2022) Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA. Front. Allergy 3:1001078. doi: 10.3389/falgy.2022.1001078

Received: 22 July 2022; Accepted: 22 August 2022;
Published: 9 September 2022.

Edited by:

Frontiers In Allergy Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Lindsay Cypers lindsay.cypers@euforea.eu

Specialty Section: This article was submitted to Rhinology, a section of the journal Frontiers in Allergy

© 2022 De Prins, Raap, Mueller, Schmid-Grendelmeier, Haase, Backer, Fokkens, Benoist, Prokopakis, Hopkins, Claeys, Teeling, Cypers, Cools, Bjermer, Diamant, Wahn, Scadding, Bachert, Patel, Van Staeyen and Hellings. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.